Carrageenan and insulin resistance in humans: a randomised double-blind cross-over trial.

ABSTRACT:

Background

The potential impact of specific food additives, common in Western diets, on the risk of developing type 2 diabetes is not well understood. This study focuses on carrageenan, a widely used food additive known to induce insulin resistance and gut inflammation in animal models, and its effects on human health.

Methods

In a randomised, double-blind, placebo-controlled, cross-over trial conducted at a university hospital metabolic study centre, 20 males (age 27.4 ± 4.3 years, BMI 24.5 ± 2.5 kg/m²) participated. The intervention involved oral intake of carrageenan (250 mg) or placebo in the morning and in the evening and each intervention lasted 2 weeks. The primary outcome measured was insulin sensitivity (using oral glucose tolerance test [OGTT] and hyperi

SUBMITTER: Wagner R 

PROVIDER: S-EPMC11590543 | biostudies-literature | 2024 Nov

REPOSITORIES: biostudies-literature